Member Info for graking

And doesn't stop the MM's making a nice profit prior to it bouncing down again. Being seriously toyed with along with many other AIMs. This company needs a big investor just before or after it announces a world beating and patented process. Hoipe springs eternal.

I suspect that will be the next RNS

Nice to know but changing the shape of an existing item is not rocket science. Worthy of an entry in a sales brochure and a circular to existing buyers.

As a general rule on AIM, unless the news is profoundly good or bad then many buyers/sellers move in and the MM's do not then control the market to their advantage. A major discovery, a life changing invention/development or a takeover by a major company are usually what provides us mere mortals with good profit - unless the MM's have over many months been reducing the price in the hope they can profit substantially on the news. Perhaps this is happening here.

Shame the MM's have a different view. Currently being shorted for end of month gains

unless you are a market maker who by todays pricing clearly prefer cables to charge up their walkmen and pacemakers

Nice buy but also shows no more business related RNS's for at least 2 weeks

Lets be honest. Either the company is incompetent in its approach OR the MHRA, being an indirect arm of the NHS/Government is hell bent on slowing down a process which ultimately will put pressure on NICE to spend more money on new developments in the present economic climate. Call me cynical or even a conspiracy theorist but when the NHS is not performing to full capacity as at present, the Exchequer is saving countless £ billions per year

The markets havn't got you message just yet

has clearly worked in this instance

Ocado must have a limit of skilled personnel ceiling for design specifications, procurement and finally installation/commissioning cannot be spread that thinly across the globe. Some subcontracting I assume but that too has its limitations so not expecting too many "partnerships" (sounds like that weird John Lewis word) for some time to come. However, if they can somehow merge their operation perhaps into some US go getting engineering conglomerate such as Tesla. then growth could be enormous.

Bladderman - I do agree for not one of these partnerships has yet proven profitable but the future may bode better

a sale must be the favorite

BUT will this make profit ?

I have always wondered why RNS statementss have never been subjected to external auduit as to their accuracy. I suspect if they were, the AIM market would collapse.

https://www.dailymail.co.uk/news/article-11320857/Husband-wife-team-say-cancer-vaccine-accessible-patients-DECADE.html

If GSK has a product that they have spent zillions on developing and are ready to promote, they do not want competition, especially from within their own ranks. There is also an agreement amongst big Pharm that they will not sit on a potential medicine development merely to protect another more developed drug. This science will be adopted by another very soon but the Stock market prevents holding off from an announcement until better news arrives. HOLD

afoot

No data yet which links so called long covid invalidity to the largely untested vaccines and their ongoing boosters. If long covid invalidity increases in proportion to the ongoing take up of boosters that would be global political dynamite. As sure as night follows day there will never be any government sponsored research into that. Another aspect is the severity of long covid. There has been discussion about the more severe cases but not the potential millions who continue to suffer some relatively minor issues, often evidenced via lack of energy or perambulatory difficulties.

will have a dramatic effect on gold prices